336 related articles for article (PubMed ID: 24531327)
1. Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma.
Gunawardana J; Chan FC; Telenius A; Woolcock B; Kridel R; Tan KL; Ben-Neriah S; Mottok A; Lim RS; Boyle M; Rogic S; Rimsza LM; Guiter C; Leroy K; Gaulard P; Haioun C; Marra MA; Savage KJ; Connors JM; Shah SP; Gascoyne RD; Steidl C
Nat Genet; 2014 Apr; 46(4):329-35. PubMed ID: 24531327
[TBL] [Abstract][Full Text] [Related]
2. The PTP1B mutant PTP1B∆2-4 is a positive regulator of the JAK/STAT signalling pathway in Hodgkin lymphoma.
Zahn M; Kaluszniak B; Möller P; Marienfeld R
Carcinogenesis; 2021 Apr; 42(4):517-527. PubMed ID: 33382412
[TBL] [Abstract][Full Text] [Related]
3. A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma.
Durand M; Cabaud Gibouin V; Duplomb L; Salmi L; Caillot M; Sola B; Camus V; Jardin F; Garrido C; Jego G
J Exp Clin Cancer Res; 2024 May; 43(1):148. PubMed ID: 38773631
[TBL] [Abstract][Full Text] [Related]
4. Biochemical, Enzymatic, and Computational Characterization of Recurrent Somatic Mutations of the Human Protein Tyrosine Phosphatase PTP1B in Primary Mediastinal B Cell Lymphoma.
Liu R; Sun Y; Berthelet J; Bui LC; Xu X; Viguier M; Dupret JM; Deshayes F; Rodrigues Lima F
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806064
[TBL] [Abstract][Full Text] [Related]
5. Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma.
Kim SJ; Yoon DH; Kang HJ; Hong JY; Lee HS; Oh SY; Shin HJ; Kong JH; Yi JH; Sakamoto K; Ko YH; Huh J; Lee SS; Takeuchi K; Shin DY; Suh C; Kim WS
BMC Cancer; 2019 Nov; 19(1):1080. PubMed ID: 31707975
[TBL] [Abstract][Full Text] [Related]
6. A novel PTPN1 splice variant upregulates JAK/STAT activity in classical Hodgkin lymphoma cells.
Zahn M; Marienfeld R; Melzner I; Heinrich J; Renner B; Wegener S; Mießner A; Barth TF; Dorsch K; Brüderlein S; Möller P
Blood; 2017 Mar; 129(11):1480-1490. PubMed ID: 28082443
[TBL] [Abstract][Full Text] [Related]
7. Discordant lymphoma consisting of mediastinal large B-cell lymphoma and nodular sclerosis Hodgkin lymphoma in the right supraclavicular lymph nodes: a case report.
Zhang C; Yi Y; Chen C; Wang J; Liu Z
Diagn Pathol; 2015 Dec; 10():215. PubMed ID: 26715530
[TBL] [Abstract][Full Text] [Related]
8. Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation.
Viganò E; Gunawardana J; Mottok A; Van Tol T; Mak K; Chan FC; Chong L; Chavez E; Woolcock B; Takata K; Twa D; Shulha HP; Telenius A; Kutovaya O; Hung SS; Healy S; Ben-Neriah S; Leroy K; Gaulard P; Diepstra A; Kridel R; Savage KJ; Rimsza L; Gascoyne R; Steidl C
Blood; 2018 May; 131(18):2036-2046. PubMed ID: 29467182
[TBL] [Abstract][Full Text] [Related]
9. Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines.
Dai H; Ehrentraut S; Nagel S; Eberth S; Pommerenke C; Dirks WG; Geffers R; Kalavalapalli S; Kaufmann M; Meyer C; Faehnrich S; Chen S; Drexler HG; MacLeod RA
PLoS One; 2015; 10(11):e0139663. PubMed ID: 26599546
[TBL] [Abstract][Full Text] [Related]
10. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.
Traverse-Glehen A; Pittaluga S; Gaulard P; Sorbara L; Alonso MA; Raffeld M; Jaffe ES
Am J Surg Pathol; 2005 Nov; 29(11):1411-21. PubMed ID: 16224207
[TBL] [Abstract][Full Text] [Related]
11. Absence of the JAK2 V617F activating mutation in classical Hodgkin lymphoma and primary mediastinal B-cell lymphoma.
Melzner I; Weniger MA; Menz CK; Möller P
Leukemia; 2006 Jan; 20(1):157-8. PubMed ID: 16331280
[No Abstract] [Full Text] [Related]
12. How I treat primary mediastinal B-cell lymphoma.
Giulino-Roth L
Blood; 2018 Aug; 132(8):782-790. PubMed ID: 29976557
[TBL] [Abstract][Full Text] [Related]
13. [Unclassified B-cell lymphomas with "grey zone" characteristics].
Chen DB; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):278-81. PubMed ID: 21616011
[No Abstract] [Full Text] [Related]
14. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.
Rosenwald A; Wright G; Leroy K; Yu X; Gaulard P; Gascoyne RD; Chan WC; Zhao T; Haioun C; Greiner TC; Weisenburger DD; Lynch JC; Vose J; Armitage JO; Smeland EB; Kvaloy S; Holte H; Delabie J; Campo E; Montserrat E; Lopez-Guillermo A; Ott G; Muller-Hermelink HK; Connors JM; Braziel R; Grogan TM; Fisher RI; Miller TP; LeBlanc M; Chiorazzi M; Zhao H; Yang L; Powell J; Wilson WH; Jaffe ES; Simon R; Klausner RD; Staudt LM
J Exp Med; 2003 Sep; 198(6):851-62. PubMed ID: 12975453
[TBL] [Abstract][Full Text] [Related]
15. Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.
Jardin F; Pujals A; Pelletier L; Bohers E; Camus V; Mareschal S; Dubois S; Sola B; Ochmann M; Lemonnier F; Viailly PJ; Bertrand P; Maingonnat C; Traverse-Glehen A; Gaulard P; Damotte D; Delarue R; Haioun C; Argueta C; Landesman Y; Salles G; Jais JP; Figeac M; Copie-Bergman C; Molina TJ; Picquenot JM; Cornic M; Fest T; Milpied N; Lemasle E; Stamatoullas A; Moeller P; Dyer MJ; Sundstrom C; Bastard C; Tilly H; Leroy K
Am J Hematol; 2016 Sep; 91(9):923-30. PubMed ID: 27312795
[TBL] [Abstract][Full Text] [Related]
16. 3D nuclear organization of telomeres in the Hodgkin cell lines U-HO1 and U-HO1-PTPN1: PTPN1 expression prevents the formation of very short telomeres including "t-stumps".
Knecht H; Brüderlein S; Wegener S; Lichtensztejn D; Lichtensztejn Z; Lemieux B; Möller P; Mai S
BMC Cell Biol; 2010 Dec; 11():99. PubMed ID: 21144060
[TBL] [Abstract][Full Text] [Related]
17. Dynamic mathematical modeling of IL13-induced signaling in Hodgkin and primary mediastinal B-cell lymphoma allows prediction of therapeutic targets.
Raia V; Schilling M; Böhm M; Hahn B; Kowarsch A; Raue A; Sticht C; Bohl S; Saile M; Möller P; Gretz N; Timmer J; Theis F; Lehmann WD; Lichter P; Klingmüller U
Cancer Res; 2011 Feb; 71(3):693-704. PubMed ID: 21127196
[TBL] [Abstract][Full Text] [Related]
18. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
Schmitz R; Hansmann ML; Bohle V; Martin-Subero JI; Hartmann S; Mechtersheimer G; Klapper W; Vater I; Giefing M; Gesk S; Stanelle J; Siebert R; Küppers R
J Exp Med; 2009 May; 206(5):981-9. PubMed ID: 19380639
[TBL] [Abstract][Full Text] [Related]
19. U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma.
Sambade C; Berglund M; Lagercrantz S; Sällström J; Reis RM; Enblad G; Glimelius B; Sundström C
Int J Cancer; 2006 Feb; 118(3):555-63. PubMed ID: 16106419
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas.
Menter T; Bodmer-Haecki A; Dirnhofer S; Tzankov A
Hum Pathol; 2016 Aug; 54():17-24. PubMed ID: 27045512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
